Cardinal Health, Inc. Cardinal Health, Inc.

Cardinal Health, Inc.

CAH

株式のランク #403
Cardinal Health, Inc. operates as a global, integrated provider of healthcare... Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.
株価
$257.03
最終同期: 2026-10-20
時価総額
$59.52B
変化(1日)
1.57%
変化(1年)
61.98%
国
US
取引 Cardinal Health, Inc. (CAH)

カテゴリー

Healthcare
Cardinal Health, Inc.(CAH)のP/E比率
October 2026 時点のP/E比率 TTM 34.08
Cardinal Health, Inc. の最新の財務報告および株価によると、現在の P/E (TTM) は 34.08 です。2024 年末時点での P/E は 28.11 でした。
Cardinal Health, Inc. の P/E 比率の履歴(2000 〜 2026)
各年末のP/E比率
年 P/E比率 変化
2026 (TTM) 34.08 31.37%
2025 25.94 -7.74%
2024 28.11 -62.42%
2023 74.80 -581.09%
2022 -15.55 -156.98%
2021 27.28 -758.91%
2020 -4.14 -139.56%
2019 10.47 -82.47%
2018 59.70 211.31%
2017 19.18 7.28%
2016 17.88 -21.79%
2015 22.86 14.00%
2014 20.05 -58.73%
2013 48.59 258.45%
2012 13.55 -17.90%
2011 16.51 -12.08%
2010 18.78 175.63%
2009 6.81 -33.21%
2008 10.20 -1.65%
2007 10.37 -46.68%
2006 19.45 14.79%
2005 16.95 16.93%
2004 14.49 -1.16%
2003 14.66 -15.53%
2002 17.36 -33.44%
2001 26.08 12.25%
2000 23.23 0.00%
類似企業や競合他社のP/E比率
企業 P/E比率 P/E比率の差 国
26.02 -23.64%
US
- -
US
- -
US
45.62 33.86%
AU
24.73 -27.43%
US
P/E比率の読み方

株価収益率(P/E Ratio)は、企業の株価と1株あたり利益の関係を示します。
低いが正のP/Eは、現在の評価額に対して高い利益を上げている企業を示し、割安と見なされる可能性があります。高い負の(0に近い)P/Eは、損失が大きいことを示します。

P/Eが30を超えるか、負である企業は一般に「成長株」と見なされ、投資家は将来的な成長または黒字化を期待しています。

10未満の正のP/Eを持つ企業は一般に「割安株」と見なされ、既に収益性が高いが成長の余地は小さいと見なされます。